Literature DB >> 1999465

A photoreceptor calcium binding protein is recognized by autoantibodies obtained from patients with cancer-associated retinopathy.

A S Polans1, J Buczyłko, J Crabb, K Palczewski.   

Abstract

Cancer-associated retinopathy (CAR), a paraneoplastic syndrome, is characterized by the degeneration of retinal photoreceptors under conditions where the tumor and its metastases have not invaded the eye. The retinopathy often is apparent before the diagnosis of cancer and may be associated with autoantibodies that react with specific sites in the retina. We have examined the sera from patients with CAR to further characterize the retinal antigen. Western blot analysis of human retinal proteins reveals a prominent band at 26 kD that is labeled by the CAR antisera. Antibodies to the 26-kD protein were affinity-purified from complex CAR antisera and used for EM-immunocytochemical localization of the protein to the nuclei, inner and outer segments of both rod and cone cells. Other antibodies obtained from the CAR sera did not label photoreceptors. Using the affinity-purified antibodies for detection, the 26-kD protein, designated p26, was purified to homogeneity from the outer segments of bovine rod photoreceptor cells by Phenyl-Sepharose and ion exchange chromatography. Partial amino acid sequence of p26 was determined by gas phase Edman degradation and revealed extensive homology with a cone-specific protein, visinin. Based upon structural relatedness, both the p26 rod protein and visinin are members of the calmodulin family and contain calcium binding domains of the E-F hand structure.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1999465      PMCID: PMC2288874          DOI: 10.1083/jcb.112.5.981

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  41 in total

1.  Primary sensory neuropathy with muscular changes associated with carcinoma.

Authors:  D DENNY-BROWN
Journal:  J Neurol Neurosurg Psychiatry       Date:  1948-05       Impact factor: 10.154

2.  Cancer-associated retinopathy (CAR syndrome) with antibodies reacting with retinal, optic-nerve, and cancer cells.

Authors:  C E Thirkill; P FitzGerald; R C Sergott; A M Roth; N K Tyler; J L Keltner
Journal:  N Engl J Med       Date:  1989-12-07       Impact factor: 91.245

3.  Autoantibody synthesis in the central nervous system of patients with paraneoplastic syndromes.

Authors:  H F Furneaux; L Reich; J B Posner
Journal:  Neurology       Date:  1990-07       Impact factor: 9.910

4.  Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa.

Authors:  H Schägger; G von Jagow
Journal:  Anal Biochem       Date:  1987-11-01       Impact factor: 3.365

5.  IgG from patients with Lambert-Eaton syndrome blocks voltage-dependent calcium channels.

Authors:  Y I Kim; E Neher
Journal:  Science       Date:  1988-01-22       Impact factor: 47.728

Review 6.  Lambert-Eaton myasthenic syndrome.

Authors:  J Newsom-Davis
Journal:  Springer Semin Immunopathol       Date:  1985

7.  Anticerebellar antibodies in serum and cerebrospinal fluid of a patient with oat cell carcinoma of the lung and paraneoplastic cerebellar degeneration.

Authors:  J E Greenlee; H L Lipton
Journal:  Ann Neurol       Date:  1986-01       Impact factor: 10.422

8.  The carcinomatous neuromyopathy of oat cell lung cancer.

Authors:  R J Hawley; M H Cohen; N Saini; V W Armbrustmacher
Journal:  Ann Neurol       Date:  1980-01       Impact factor: 10.422

9.  Photoreceptor degeneration. Possible autoimmune disorder.

Authors:  J L Keltner; A M Roth; R S Chang
Journal:  Arch Ophthalmol       Date:  1983-04

10.  Calretinin: a gene for a novel calcium-binding protein expressed principally in neurons.

Authors:  J H Rogers
Journal:  J Cell Biol       Date:  1987-09       Impact factor: 10.539

View more
  35 in total

1.  Autoantibodies to photoreceptor membrane proteins and outer plexiform layer in patients with cancer-associated retinopathy.

Authors:  R Peek; B G Dijkstra; B Meek; R W A M Kuijpers
Journal:  Clin Exp Immunol       Date:  2002-06       Impact factor: 4.330

2.  Genetic polymorphism and protein conformational plasticity in the calmodulin superfamily: two ways to promote multifunctionality.

Authors:  Mitsuhiko Ikura; James B Ames
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-23       Impact factor: 11.205

Review 3.  Paraneoplastic syndromes associated with lung cancer.

Authors:  Nobuhiro Kanaji; Naoki Watanabe; Nobuyuki Kita; Shuji Bandoh; Akira Tadokoro; Tomoya Ishii; Hiroaki Dobashi; Takuya Matsunaga
Journal:  World J Clin Oncol       Date:  2014-08-10

4.  Latest updates on antiretinal autoantibodies associated with vision loss and breast cancer.

Authors:  Grazyna Adamus
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-03-09       Impact factor: 4.799

5.  Auto-immune-like cone dystrophy.

Authors:  János Hargitai; Cynthia MacKay; Myles Behrens; Jeffrey G Odel; Donald C Hood; Peter Gouras
Journal:  Doc Ophthalmol       Date:  2004-11       Impact factor: 2.379

6.  Distribution pattern of three neural calcium-binding proteins (NCS-1, VILIP and recoverin) in chicken, bovine and rat retina.

Authors:  S De Raad; M Comte; P Nef; S E Lenz; E D Gundelfinger; J A Cox
Journal:  Histochem J       Date:  1995-07

7.  Severe course of cutaneous melanoma associated paraneoplastic retinopathy.

Authors:  U Kellner; N Bornfeld; M H Foerster
Journal:  Br J Ophthalmol       Date:  1995-08       Impact factor: 4.638

Review 8.  Onconeural antigens and the paraneoplastic neurologic disorders: at the intersection of cancer, immunity, and the brain.

Authors:  R B Darnell
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

9.  Cloning, expression, and crystallization of recoverin, a calcium sensor in vision.

Authors:  S Ray; S Zozulya; G A Niemi; K M Flaherty; D Brolley; A M Dizhoor; D B McKay; J Hurley; L Stryer
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-01       Impact factor: 11.205

10.  Autoantibodies against the Ca(2+)-binding protein recoverin in blood sera of patients with various oncological diseases.

Authors:  Marina S Savchenko; Maria A Goncharskaia; Elena E Skorikova; Stefan B Eichmüller; Nikolay E Kushlinsky; Alexandr V Bazhin; Pavel P Philippov
Journal:  Oncol Lett       Date:  2011-10-31       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.